

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 5.11725782 |
| 2 | detection of other organism (GO:0098543) | 5.01435903 |
| 3 | detection of molecule of bacterial origin (GO:0032490) | 4.96705994 |
| 4 | detection of external biotic stimulus (GO:0098581) | 4.62291363 |
| 5 | detection of bacterium (GO:0016045) | 4.60393200 |
| 6 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.37548467 |
| 7 | macrophage activation involved in immune response (GO:0002281) | 4.33455152 |
| 8 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.25351819 |
| 9 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.25351819 |
| 10 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.11119290 |
| 11 | detection of biotic stimulus (GO:0009595) | 4.02723921 |
| 12 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.01160457 |
| 13 | response to host immune response (GO:0052572) | 4.01160457 |
| 14 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 4.00256867 |
| 15 | positive regulation of B cell differentiation (GO:0045579) | 3.98670167 |
| 16 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.94927363 |
| 17 | response to host (GO:0075136) | 3.86642559 |
| 18 | response to host defenses (GO:0052200) | 3.86642559 |
| 19 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.86642559 |
| 20 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.69647367 |
| 21 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.66512957 |
| 22 | microglial cell activation (GO:0001774) | 3.65146744 |
| 23 | neutrophil activation (GO:0042119) | 3.61584500 |
| 24 | regulation of mast cell degranulation (GO:0043304) | 3.54219159 |
| 25 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.51535663 |
| 26 | macrophage activation (GO:0042116) | 3.49808645 |
| 27 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.47869656 |
| 28 | megakaryocyte development (GO:0035855) | 3.46161164 |
| 29 | regulation of leukocyte degranulation (GO:0043300) | 3.44941690 |
| 30 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.44670567 |
| 31 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.44670567 |
| 32 | negative regulation of phagocytosis (GO:0050765) | 3.41313338 |
| 33 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.38257212 |
| 34 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.37472149 |
| 35 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.36222051 |
| 36 | valine metabolic process (GO:0006573) | 3.31074116 |
| 37 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.30905454 |
| 38 | myeloid cell activation involved in immune response (GO:0002275) | 3.30309139 |
| 39 | definitive hemopoiesis (GO:0060216) | 3.30276229 |
| 40 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.29156182 |
| 41 | granulocyte activation (GO:0036230) | 3.26116202 |
| 42 | alpha-linolenic acid metabolic process (GO:0036109) | 3.25747750 |
| 43 | response to interleukin-15 (GO:0070672) | 3.23446847 |
| 44 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.22318842 |
| 45 | regulation of gamma-delta T cell activation (GO:0046643) | 3.19087822 |
| 46 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.11282906 |
| 47 | regulation of B cell differentiation (GO:0045577) | 3.11220474 |
| 48 | lysine metabolic process (GO:0006553) | 3.03763982 |
| 49 | lysine catabolic process (GO:0006554) | 3.03763982 |
| 50 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.00621654 |
| 51 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.00621654 |
| 52 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.00592738 |
| 53 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.99142185 |
| 54 | pentose-phosphate shunt (GO:0006098) | 2.98877594 |
| 55 | germinal center formation (GO:0002467) | 2.97355557 |
| 56 | negative regulation of T cell mediated immunity (GO:0002710) | 2.95551789 |
| 57 | pinocytosis (GO:0006907) | 2.94412436 |
| 58 | defense response to fungus (GO:0050832) | 2.93936957 |
| 59 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.93904936 |
| 60 | regulation of macrophage cytokine production (GO:0010935) | 2.92983455 |
| 61 | positive regulation of histone deacetylation (GO:0031065) | 2.87858868 |
| 62 | regulation of regulated secretory pathway (GO:1903305) | 2.86211590 |
| 63 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.85830590 |
| 64 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.83689913 |
| 65 | leukocyte degranulation (GO:0043299) | 2.83652179 |
| 66 | angiogenesis involved in wound healing (GO:0060055) | 2.82636195 |
| 67 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.81928197 |
| 68 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.81327953 |
| 69 | myeloid leukocyte mediated immunity (GO:0002444) | 2.78541288 |
| 70 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.77953095 |
| 71 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.77624545 |
| 72 | positive regulation of mast cell activation (GO:0033005) | 2.77222317 |
| 73 | negative regulation of cell killing (GO:0031342) | 2.75655604 |
| 74 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.75655604 |
| 75 | * lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.74332028 |
| 76 | protein carboxylation (GO:0018214) | 2.74318085 |
| 77 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.74318085 |
| 78 | respiratory burst (GO:0045730) | 2.74238834 |
| 79 | * response to muramyl dipeptide (GO:0032495) | 2.74040248 |
| 80 | regulation of mast cell activation (GO:0033003) | 2.73795597 |
| 81 | macrophage differentiation (GO:0030225) | 2.73462024 |
| 82 | hypotonic response (GO:0006971) | 2.73323519 |
| 83 | neutrophil mediated immunity (GO:0002446) | 2.72127101 |
| 84 | 2-oxoglutarate metabolic process (GO:0006103) | 2.70701013 |
| 85 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.69707454 |
| 86 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.69322256 |
| 87 | regulation of necroptotic process (GO:0060544) | 2.69148008 |
| 88 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.68290450 |
| 89 | L-phenylalanine metabolic process (GO:0006558) | 2.67461398 |
| 90 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.67461398 |
| 91 | complement activation, alternative pathway (GO:0006957) | 2.67457463 |
| 92 | killing of cells of other organism (GO:0031640) | 2.66663701 |
| 93 | disruption of cells of other organism (GO:0044364) | 2.66663701 |
| 94 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.65451269 |
| 95 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.64383197 |
| 96 | L-phenylalanine catabolic process (GO:0006559) | 2.64383197 |
| 97 | necroptotic process (GO:0070266) | 2.64254325 |
| 98 | immunoglobulin mediated immune response (GO:0016064) | 2.63435978 |
| 99 | aromatic amino acid family catabolic process (GO:0009074) | 2.62968491 |
| 100 | negative regulation of interleukin-12 production (GO:0032695) | 2.62356176 |
| 101 | B cell receptor signaling pathway (GO:0050853) | 2.61893844 |
| 102 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.61102050 |
| 103 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.59974884 |
| 104 | negative regulation of interleukin-6 production (GO:0032715) | 2.59584662 |
| 105 | negative regulation of interleukin-17 production (GO:0032700) | 2.58744655 |
| 106 | sulfur amino acid catabolic process (GO:0000098) | 2.58698246 |
| 107 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.58269241 |
| 108 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.57013259 |
| 109 | regulation of platelet aggregation (GO:0090330) | 2.56437093 |
| 110 | positive regulation of leukocyte degranulation (GO:0043302) | 2.55584812 |
| 111 | kynurenine metabolic process (GO:0070189) | 2.55564004 |
| 112 | urea metabolic process (GO:0019627) | 2.53789402 |
| 113 | urea cycle (GO:0000050) | 2.53789402 |
| 114 | myeloid leukocyte activation (GO:0002274) | 2.53213786 |
| 115 | NADPH regeneration (GO:0006740) | 2.52676860 |
| 116 | neutrophil chemotaxis (GO:0030593) | 2.52390157 |
| 117 | type I interferon signaling pathway (GO:0060337) | 2.52244060 |
| 118 | cellular response to type I interferon (GO:0071357) | 2.52244060 |
| 119 | response to type I interferon (GO:0034340) | 2.52049603 |
| 120 | DNA unwinding involved in DNA replication (GO:0006268) | 2.51667723 |
| 121 | tricarboxylic acid metabolic process (GO:0072350) | 2.51455501 |
| 122 | embryonic process involved in female pregnancy (GO:0060136) | 2.50761972 |
| 123 | indole-containing compound catabolic process (GO:0042436) | 2.50735078 |
| 124 | indolalkylamine catabolic process (GO:0046218) | 2.50735078 |
| 125 | tryptophan catabolic process (GO:0006569) | 2.50735078 |
| 126 | glycine metabolic process (GO:0006544) | 2.50308194 |
| 127 | IMP metabolic process (GO:0046040) | 2.49327622 |
| 128 | response to fungus (GO:0009620) | 2.48087667 |
| 129 | modulation by symbiont of host defense response (GO:0052031) | 2.46248879 |
| 130 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.46248879 |
| 131 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.46248879 |
| 132 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.46248879 |
| 133 | modulation by symbiont of host immune response (GO:0052553) | 2.46248879 |
| 134 | positive regulation by symbiont of host defense response (GO:0052509) | 2.46248879 |
| 135 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.44962688 |
| 136 | amino-acid betaine metabolic process (GO:0006577) | 2.43971632 |
| 137 | negative regulation of granulocyte differentiation (GO:0030853) | 2.43820865 |
| 138 | oxaloacetate metabolic process (GO:0006107) | 2.42089747 |
| 139 | response to peptidoglycan (GO:0032494) | 2.41784755 |
| 140 | glyoxylate metabolic process (GO:0046487) | 2.40784635 |
| 141 | positive regulation of lamellipodium assembly (GO:0010592) | 2.40063717 |
| 142 | IMP biosynthetic process (GO:0006188) | 2.39621371 |
| 143 | regulation of triglyceride catabolic process (GO:0010896) | 2.39027971 |
| 144 | positive regulation of protein deacetylation (GO:0090312) | 2.38928483 |
| 145 | positive thymic T cell selection (GO:0045059) | 2.37272638 |
| 146 | regulation of protein activation cascade (GO:2000257) | 2.36644043 |
| 147 | B cell mediated immunity (GO:0019724) | 2.35071738 |
| 148 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.33810746 |
| 149 | mannose metabolic process (GO:0006013) | 2.33394047 |
| 150 | natural killer cell differentiation (GO:0001779) | 2.32661453 |
| 151 | regulation of cholesterol homeostasis (GO:2000188) | 2.31241878 |
| 152 | tryptophan metabolic process (GO:0006568) | 2.31003533 |
| 153 | glucose 6-phosphate metabolic process (GO:0051156) | 2.30502751 |
| 154 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.29473527 |
| 155 | cellular extravasation (GO:0045123) | 2.29290779 |
| 156 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.29249613 |
| 157 | T cell homeostasis (GO:0043029) | 2.29134010 |
| 158 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.29091405 |
| 159 | defense response to protozoan (GO:0042832) | 2.29012473 |
| 160 | leukocyte aggregation (GO:0070486) | 2.28239815 |
| 161 | regulation of complement activation (GO:0030449) | 2.26865684 |
| 162 | positive regulation of interferon-alpha production (GO:0032727) | 2.26419087 |
| 163 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.25740183 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.20965133 |
| 2 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.78435829 |
| 3 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.12323674 |
| 4 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.95407820 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.93412564 |
| 6 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.92696953 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 2.83186748 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.82022309 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.66284298 |
| 10 | GATA1_22025678_ChIP-Seq_K562_Human | 2.63414413 |
| 11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.61151011 |
| 12 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.57926593 |
| 13 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.49692966 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.42166552 |
| 15 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.41689676 |
| 16 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.41428935 |
| 17 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.35383755 |
| 18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.30816190 |
| 19 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.26279513 |
| 20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.25904630 |
| 21 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.25128907 |
| 22 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.22764616 |
| 23 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.14289049 |
| 24 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.11047576 |
| 25 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.09516834 |
| 26 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.05824695 |
| 27 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.94387317 |
| 28 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.88742323 |
| 29 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.88441326 |
| 30 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.87344039 |
| 31 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.84575099 |
| 32 | MAF_26560356_Chip-Seq_TH1_Human | 1.83926836 |
| 33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.83058160 |
| 34 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.82378549 |
| 35 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.79230490 |
| 36 | UTX_26944678_Chip-Seq_JUKART_Human | 1.69033130 |
| 37 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66496630 |
| 38 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.65319999 |
| 39 | * MYB_26560356_Chip-Seq_TH1_Human | 1.63392596 |
| 40 | MYB_26560356_Chip-Seq_TH2_Human | 1.61889722 |
| 41 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.61189011 |
| 42 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.58806700 |
| 43 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.58773192 |
| 44 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.57818719 |
| 45 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.57211172 |
| 46 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.57154807 |
| 47 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53446482 |
| 48 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.52767239 |
| 49 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.52726514 |
| 50 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.51578597 |
| 51 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.50932615 |
| 52 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50849023 |
| 53 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.48637428 |
| 54 | SPI1_23127762_ChIP-Seq_K562_Human | 1.45921817 |
| 55 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.43105779 |
| 56 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.40122715 |
| 57 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.39314036 |
| 58 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.36468361 |
| 59 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.36110422 |
| 60 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.35515287 |
| 61 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.32791593 |
| 62 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.32728808 |
| 63 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.32502532 |
| 64 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.30342020 |
| 65 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.30206901 |
| 66 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.29966744 |
| 67 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29855937 |
| 68 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.29535507 |
| 69 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.28614814 |
| 70 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.26490984 |
| 71 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.24493111 |
| 72 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.22139566 |
| 73 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21183125 |
| 74 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.21069370 |
| 75 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20395411 |
| 76 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.19670300 |
| 77 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.18295993 |
| 78 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.17949125 |
| 79 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.17847462 |
| 80 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17052453 |
| 81 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.15512857 |
| 82 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12597759 |
| 83 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.12344106 |
| 84 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.12280563 |
| 85 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11942092 |
| 86 | MAF_26560356_Chip-Seq_TH2_Human | 1.10690772 |
| 87 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.09737212 |
| 88 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.09481322 |
| 89 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08502139 |
| 90 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.08188995 |
| 91 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.06762139 |
| 92 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.06268300 |
| 93 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.05156764 |
| 94 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.03802683 |
| 95 | GATA1_19941826_ChIP-Seq_K562_Human | 1.03184533 |
| 96 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03070058 |
| 97 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02655353 |
| 98 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.02600732 |
| 99 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02052231 |
| 100 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.02019066 |
| 101 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98613855 |
| 102 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97512942 |
| 103 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.97459824 |
| 104 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.96468226 |
| 105 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96439233 |
| 106 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.94818592 |
| 107 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94660755 |
| 108 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94552859 |
| 109 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.93740963 |
| 110 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92972972 |
| 111 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.92925138 |
| 112 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.92819602 |
| 113 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.92496729 |
| 114 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91623138 |
| 115 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.91097552 |
| 116 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.90974577 |
| 117 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.90645410 |
| 118 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90310140 |
| 119 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.89860077 |
| 120 | GATA2_19941826_ChIP-Seq_K562_Human | 0.88114738 |
| 121 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87988311 |
| 122 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.86964582 |
| 123 | * CLOCK_20551151_ChIP-Seq_293T_Human | 0.86953973 |
| 124 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.85183700 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003191_abnormal_cellular_cholesterol | 3.09382389 |
| 2 | MP0002396_abnormal_hematopoietic_system | 2.96008077 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 2.83416109 |
| 4 | MP0008260_abnormal_autophagy | 2.76346045 |
| 5 | MP0005360_urolithiasis | 2.71198221 |
| 6 | MP0003436_decreased_susceptibility_to | 2.64978805 |
| 7 | MP0005365_abnormal_bile_salt | 2.63922750 |
| 8 | MP0005464_abnormal_platelet_physiology | 2.59102696 |
| 9 | MP0001835_abnormal_antigen_presentation | 2.40687206 |
| 10 | MP0003303_peritoneal_inflammation | 2.38293243 |
| 11 | MP0009840_abnormal_foam_cell | 2.31402520 |
| 12 | MP0003828_pulmonary_edema | 2.29261659 |
| 13 | MP0005085_abnormal_gallbladder_physiolo | 2.26195296 |
| 14 | MP0005451_abnormal_body_composition | 2.24176078 |
| 15 | MP0005058_abnormal_lysosome_morphology | 2.16144279 |
| 16 | MP0005397_hematopoietic_system_phenotyp | 2.07741310 |
| 17 | MP0001545_abnormal_hematopoietic_system | 2.07741310 |
| 18 | MP0003300_gastrointestinal_ulcer | 1.98233496 |
| 19 | MP0002419_abnormal_innate_immunity | 1.96052585 |
| 20 | MP0008875_abnormal_xenobiotic_pharmacok | 1.95314719 |
| 21 | MP0003252_abnormal_bile_duct | 1.95231594 |
| 22 | MP0004808_abnormal_hematopoietic_stem | 1.90405404 |
| 23 | MP0000685_abnormal_immune_system | 1.84906808 |
| 24 | MP0001800_abnormal_humoral_immune | 1.84082203 |
| 25 | MP0010329_abnormal_lipoprotein_level | 1.80684059 |
| 26 | MP0005025_abnormal_response_to | 1.77033578 |
| 27 | MP0009278_abnormal_bone_marrow | 1.75653588 |
| 28 | MP0003172_abnormal_lysosome_physiology | 1.75472420 |
| 29 | MP0009785_altered_susceptibility_to | 1.71962953 |
| 30 | MP0002452_abnormal_antigen_presenting | 1.68010096 |
| 31 | MP0002877_abnormal_melanocyte_morpholog | 1.67896457 |
| 32 | MP0005000_abnormal_immune_tolerance | 1.64346424 |
| 33 | MP0001851_eye_inflammation | 1.63443420 |
| 34 | MP0002132_abnormal_respiratory_system | 1.63151568 |
| 35 | MP0005671_abnormal_response_to | 1.61854305 |
| 36 | * MP0002398_abnormal_bone_marrow | 1.60229873 |
| 37 | MP0003656_abnormal_erythrocyte_physiolo | 1.59725820 |
| 38 | * MP0002723_abnormal_immune_serum | 1.57500694 |
| 39 | * MP0002420_abnormal_adaptive_immunity | 1.56423623 |
| 40 | MP0000689_abnormal_spleen_morphology | 1.56241717 |
| 41 | * MP0001819_abnormal_immune_cell | 1.54410163 |
| 42 | MP0000609_abnormal_liver_physiology | 1.51651103 |
| 43 | MP0002166_altered_tumor_susceptibility | 1.50565213 |
| 44 | MP0003724_increased_susceptibility_to | 1.49960236 |
| 45 | MP0005174_abnormal_tail_pigmentation | 1.49315522 |
| 46 | MP0001790_abnormal_immune_system | 1.48332482 |
| 47 | MP0005387_immune_system_phenotype | 1.48332482 |
| 48 | MP0001853_heart_inflammation | 1.45780184 |
| 49 | MP0002722_abnormal_immune_system | 1.44575759 |
| 50 | MP0003806_abnormal_nucleotide_metabolis | 1.43926122 |
| 51 | MP0005075_abnormal_melanosome_morpholog | 1.43303902 |
| 52 | MP0008004_abnormal_stomach_pH | 1.42509406 |
| 53 | * MP0000716_abnormal_immune_system | 1.41896360 |
| 54 | MP0000465_gastrointestinal_hemorrhage | 1.41005221 |
| 55 | MP0001845_abnormal_inflammatory_respons | 1.40798535 |
| 56 | MP0010352_gastrointestinal_tract_polyps | 1.40568902 |
| 57 | MP0008469_abnormal_protein_level | 1.40002209 |
| 58 | MP0010155_abnormal_intestine_physiology | 1.37360113 |
| 59 | MP0004883_abnormal_blood_vessel | 1.35142311 |
| 60 | MP0005076_abnormal_cell_differentiation | 1.33780311 |
| 61 | MP0000490_abnormal_crypts_of | 1.33577761 |
| 62 | MP0003763_abnormal_thymus_physiology | 1.33112968 |
| 63 | * MP0002429_abnormal_blood_cell | 1.32888407 |
| 64 | MP0003183_abnormal_peptide_metabolism | 1.29838200 |
| 65 | MP0005319_abnormal_enzyme/_coenzyme | 1.29815253 |
| 66 | MP0002998_abnormal_bone_remodeling | 1.27802632 |
| 67 | MP0002405_respiratory_system_inflammati | 1.26706182 |
| 68 | MP0005164_abnormal_response_to | 1.24773201 |
| 69 | MP0004947_skin_inflammation | 1.23526046 |
| 70 | MP0005409_darkened_coat_color | 1.23149130 |
| 71 | MP0003705_abnormal_hypodermis_morpholog | 1.19981754 |
| 72 | MP0004147_increased_porphyrin_level | 1.19765773 |
| 73 | MP0004381_abnormal_hair_follicle | 1.19102237 |
| 74 | MP0000371_diluted_coat_color | 1.18983063 |
| 75 | MP0006082_CNS_inflammation | 1.18530913 |
| 76 | MP0001533_abnormal_skeleton_physiology | 1.17619994 |
| 77 | MP0003091_abnormal_cell_migration | 1.15837575 |
| 78 | * MP0000598_abnormal_liver_morphology | 1.14187788 |
| 79 | MP0002148_abnormal_hypersensitivity_rea | 1.13911809 |
| 80 | MP0001666_abnormal_nutrient_absorption | 1.12891405 |
| 81 | MP0004130_abnormal_muscle_cell | 1.12207835 |
| 82 | MP0003566_abnormal_cell_adhesion | 1.12032401 |
| 83 | MP0009333_abnormal_splenocyte_physiolog | 1.10045432 |
| 84 | MP0003866_abnormal_defecation | 1.07027516 |
| 85 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.06417114 |
| 86 | * MP0009763_increased_sensitivity_to | 1.05319786 |
| 87 | MP0000703_abnormal_thymus_morphology | 1.04310406 |
| 88 | MP0002118_abnormal_lipid_homeostasis | 1.04207738 |
| 89 | MP0002006_tumorigenesis | 1.02124243 |
| 90 | MP0010307_abnormal_tumor_latency | 0.99703810 |
| 91 | MP0002009_preneoplasia | 0.99630823 |
| 92 | MP0001873_stomach_inflammation | 0.98871906 |
| 93 | MP0000015_abnormal_ear_pigmentation | 0.98001896 |
| 94 | MP0005083_abnormal_biliary_tract | 0.97862179 |
| 95 | MP0003075_altered_response_to | 0.97778251 |
| 96 | MP0006054_spinal_hemorrhage | 0.96548302 |
| 97 | MP0008961_abnormal_basal_metabolism | 0.94695846 |
| 98 | MP0005023_abnormal_wound_healing | 0.93260398 |
| 99 | MP0009643_abnormal_urine_homeostasis | 0.91507382 |
| 100 | MP0005332_abnormal_amino_acid | 0.91220615 |
| 101 | * MP0002019_abnormal_tumor_incidence | 0.89151163 |
| 102 | MP0003868_abnormal_feces_composition | 0.88297374 |
| 103 | MP0009764_decreased_sensitivity_to | 0.88285237 |
| 104 | MP0003448_altered_tumor_morphology | 0.87680247 |
| 105 | * MP0004264_abnormal_extraembryonic_tissu | 0.86799198 |
| 106 | MP0000858_altered_metastatic_potential | 0.86785581 |
| 107 | MP0005666_abnormal_adipose_tissue | 0.84775375 |
| 108 | MP0003186_abnormal_redox_activity | 0.84432321 |
| 109 | MP0004510_myositis | 0.83908856 |
| 110 | MP0001915_intracranial_hemorrhage | 0.83506597 |
| 111 | MP0002138_abnormal_hepatobiliary_system | 0.82828751 |
| 112 | MP0003690_abnormal_glial_cell | 0.82732607 |
| 113 | MP0004185_abnormal_adipocyte_glucose | 0.82524203 |
| 114 | MP0003453_abnormal_keratinocyte_physiol | 0.82517353 |
| 115 | MP0010094_abnormal_chromosome_stability | 0.81475018 |
| 116 | MP0008873_increased_physiological_sensi | 0.81420344 |
| 117 | MP0005166_decreased_susceptibility_to | 0.80804925 |
| 118 | MP0008057_abnormal_DNA_replication | 0.78732420 |
| 119 | * MP0000343_altered_response_to | 0.78269561 |
| 120 | MP0005390_skeleton_phenotype | 0.75275470 |
| 121 | MP0003943_abnormal_hepatobiliary_system | 0.74763588 |
| 122 | MP0001958_emphysema | 0.74624862 |
| 123 | MP0000569_abnormal_digit_pigmentation | 0.74318751 |
| 124 | MP0006036_abnormal_mitochondrial_physio | 0.74304802 |
| 125 | MP0000249_abnormal_blood_vessel | 0.73797833 |
| 126 | MP0003795_abnormal_bone_structure | 0.72239426 |
| 127 | MP0005310_abnormal_salivary_gland | 0.70296830 |
| 128 | MP0003045_fibrosis | 0.70082255 |
| 129 | * MP0005621_abnormal_cell_physiology | 0.67866501 |
| 130 | * MP0003221_abnormal_cardiomyocyte_apopto | 0.67098811 |
| 131 | MP0005375_adipose_tissue_phenotype | 0.65970716 |
| 132 | MP0000604_amyloidosis | 0.65509762 |
| 133 | MP0010234_abnormal_vibrissa_follicle | 0.64849726 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Orchitis (HP:0100796) | 3.91971497 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 3.75410321 |
| 3 | Recurrent abscess formation (HP:0002722) | 3.74526213 |
| 4 | Thrombocytosis (HP:0001894) | 3.51596804 |
| 5 | Gastrointestinal infarctions (HP:0005244) | 3.48159760 |
| 6 | Retrobulbar optic neuritis (HP:0100654) | 3.47890539 |
| 7 | Optic neuritis (HP:0100653) | 3.47890539 |
| 8 | Eczematoid dermatitis (HP:0000976) | 3.41390278 |
| 9 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.38169920 |
| 10 | Gingivitis (HP:0000230) | 3.37572324 |
| 11 | IgM deficiency (HP:0002850) | 3.27465255 |
| 12 | Systemic lupus erythematosus (HP:0002725) | 3.15805354 |
| 13 | Peritonitis (HP:0002586) | 3.05698984 |
| 14 | Deep venous thrombosis (HP:0002625) | 3.05157650 |
| 15 | Epistaxis (HP:0000421) | 2.98046273 |
| 16 | Increased IgE level (HP:0003212) | 2.97069061 |
| 17 | Complement deficiency (HP:0004431) | 2.95772224 |
| 18 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.92984938 |
| 19 | Recurrent viral infections (HP:0004429) | 2.92962282 |
| 20 | Colitis (HP:0002583) | 2.90853394 |
| 21 | Joint hemorrhage (HP:0005261) | 2.86085477 |
| 22 | Abnormal platelet function (HP:0011869) | 2.81633511 |
| 23 | Impaired platelet aggregation (HP:0003540) | 2.81633511 |
| 24 | Abnormality of the common coagulation pathway (HP:0010990) | 2.81100446 |
| 25 | Keratoconjunctivitis sicca (HP:0001097) | 2.77797286 |
| 26 | Spontaneous hematomas (HP:0007420) | 2.77490442 |
| 27 | Stomatitis (HP:0010280) | 2.76517048 |
| 28 | Gingival bleeding (HP:0000225) | 2.75756058 |
| 29 | Gastrointestinal inflammation (HP:0004386) | 2.74219730 |
| 30 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.73987581 |
| 31 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.73851693 |
| 32 | Inflammation of the large intestine (HP:0002037) | 2.73189892 |
| 33 | Hypoglycemic coma (HP:0001325) | 2.71148105 |
| 34 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.70193106 |
| 35 | Abnormality of T cell physiology (HP:0011840) | 2.66745622 |
| 36 | Hypochromic anemia (HP:0001931) | 2.64798089 |
| 37 | Prolonged bleeding time (HP:0003010) | 2.64031723 |
| 38 | Petechiae (HP:0000967) | 2.63415755 |
| 39 | Polycythemia (HP:0001901) | 2.63250810 |
| 40 | Encephalitis (HP:0002383) | 2.63007831 |
| 41 | Vasculitis (HP:0002633) | 2.62916289 |
| 42 | Recurrent skin infections (HP:0001581) | 2.62639561 |
| 43 | Hypochromic microcytic anemia (HP:0004840) | 2.60637059 |
| 44 | Granulocytopenia (HP:0001913) | 2.59946984 |
| 45 | Recurrent fungal infections (HP:0002841) | 2.57870153 |
| 46 | Abnormality of T cell number (HP:0011839) | 2.51881228 |
| 47 | Xanthomatosis (HP:0000991) | 2.51720200 |
| 48 | Hypobetalipoproteinemia (HP:0003563) | 2.51460468 |
| 49 | Abnormality of complement system (HP:0005339) | 2.50104249 |
| 50 | Myositis (HP:0100614) | 2.46331078 |
| 51 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.46064611 |
| 52 | Panhypogammaglobulinemia (HP:0003139) | 2.45657699 |
| 53 | Keratoconjunctivitis (HP:0001096) | 2.44309090 |
| 54 | Chronic otitis media (HP:0000389) | 2.40955686 |
| 55 | Cellulitis (HP:0100658) | 2.40280494 |
| 56 | Abnormality of the thoracic spine (HP:0100711) | 2.39014401 |
| 57 | T lymphocytopenia (HP:0005403) | 2.38668797 |
| 58 | Intrahepatic cholestasis (HP:0001406) | 2.38325882 |
| 59 | Increased cerebral lipofuscin (HP:0011813) | 2.38313285 |
| 60 | Thoracic kyphosis (HP:0002942) | 2.36332380 |
| 61 | Abnormality of the peritoneum (HP:0002585) | 2.35495276 |
| 62 | Autoimmune thrombocytopenia (HP:0001973) | 2.35119676 |
| 63 | Agnosia (HP:0010524) | 2.34599432 |
| 64 | Prolonged partial thromboplastin time (HP:0003645) | 2.34376005 |
| 65 | Leukocytosis (HP:0001974) | 2.31989239 |
| 66 | Hyperlipoproteinemia (HP:0010980) | 2.30745032 |
| 67 | Dysostosis multiplex (HP:0000943) | 2.28867423 |
| 68 | Subacute progressive viral hepatitis (HP:0006572) | 2.28511018 |
| 69 | Autoimmune hemolytic anemia (HP:0001890) | 2.27132531 |
| 70 | Abnormal platelet volume (HP:0011876) | 2.26824998 |
| 71 | Viral hepatitis (HP:0006562) | 2.26659671 |
| 72 | Vacuolated lymphocytes (HP:0001922) | 2.26035968 |
| 73 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.25437229 |
| 74 | Episodic fever (HP:0001954) | 2.24326444 |
| 75 | Mediastinal lymphadenopathy (HP:0100721) | 2.23324538 |
| 76 | Glomerulonephritis (HP:0000099) | 2.22959046 |
| 77 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.21168581 |
| 78 | Periodontitis (HP:0000704) | 2.20017664 |
| 79 | Meningitis (HP:0001287) | 2.19685318 |
| 80 | Ketosis (HP:0001946) | 2.18839257 |
| 81 | Abnormality of the intrinsic pathway (HP:0010989) | 2.16420130 |
| 82 | Abnormality of the fingertips (HP:0001211) | 2.15751322 |
| 83 | Mucopolysacchariduria (HP:0008155) | 2.15194073 |
| 84 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.15194073 |
| 85 | Fatigue (HP:0012378) | 2.12552311 |
| 86 | Pulmonary infiltrates (HP:0002113) | 2.10091390 |
| 87 | Hemoptysis (HP:0002105) | 2.08959040 |
| 88 | Slow saccadic eye movements (HP:0000514) | 2.07738971 |
| 89 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.07065408 |
| 90 | Menorrhagia (HP:0000132) | 2.05877992 |
| 91 | Generalized aminoaciduria (HP:0002909) | 2.05730582 |
| 92 | Hyperammonemia (HP:0001987) | 2.05613320 |
| 93 | Hematochezia (HP:0002573) | 2.05064960 |
| 94 | Abnormality of macrophages (HP:0004311) | 2.04189098 |
| 95 | Abnormality of T cells (HP:0002843) | 2.03673438 |
| 96 | Hypoplasia of the thymus (HP:0000778) | 2.01084723 |
| 97 | Eosinophilia (HP:0001880) | 2.00769217 |
| 98 | Interstitial pulmonary disease (HP:0006530) | 2.00564233 |
| 99 | Skin ulcer (HP:0200042) | 1.99460394 |
| 100 | Anorexia (HP:0002039) | 1.99032368 |
| 101 | Urticaria (HP:0001025) | 1.98783574 |
| 102 | Glomerulopathy (HP:0100820) | 1.95678005 |
| 103 | Increased mean platelet volume (HP:0011877) | 1.95675669 |
| 104 | Chest pain (HP:0100749) | 1.95214524 |
| 105 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.94550213 |
| 106 | Recurrent cutaneous fungal infections (HP:0011370) | 1.94550213 |
| 107 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.93841511 |
| 108 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.93701903 |
| 109 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.93701903 |
| 110 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.93701903 |
| 111 | Chronic obstructive pulmonary disease (HP:0006510) | 1.93567826 |
| 112 | Obstructive lung disease (HP:0006536) | 1.93567826 |
| 113 | Purpura (HP:0000979) | 1.93048941 |
| 114 | Metaphyseal cupping (HP:0003021) | 1.92177365 |
| 115 | Spastic diplegia (HP:0001264) | 1.92164974 |
| 116 | Late onset (HP:0003584) | 1.90677825 |
| 117 | Increased IgM level (HP:0003496) | 1.90533136 |
| 118 | Thrombophlebitis (HP:0004418) | 1.86632985 |
| 119 | Increased connective tissue (HP:0009025) | 1.86444526 |
| 120 | Abnormality of iron homeostasis (HP:0011031) | 1.85486451 |
| 121 | Osteomyelitis (HP:0002754) | 1.85338935 |
| 122 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.84415708 |
| 123 | Dilatation of the ascending aorta (HP:0005111) | 1.83666901 |
| 124 | Myocardial infarction (HP:0001658) | 1.82830515 |
| 125 | Hypolipoproteinemia (HP:0010981) | 1.81053241 |
| 126 | Hypergammaglobulinemia (HP:0010702) | 1.80898869 |
| 127 | Increased serum ferritin (HP:0003281) | 1.80331575 |
| 128 | Hyperbilirubinemia (HP:0002904) | 1.80184997 |
| 129 | Sepsis (HP:0100806) | 1.79919048 |
| 130 | Ulnar deviation of the wrist (HP:0003049) | 1.79548828 |
| 131 | Acute myeloid leukemia (HP:0004808) | 1.79331779 |
| 132 | Pustule (HP:0200039) | 1.78996476 |
| 133 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.78974186 |
| 134 | Difficulty running (HP:0009046) | 1.77957126 |
| 135 | Flat acetabular roof (HP:0003180) | 1.76924325 |
| 136 | Microcytic anemia (HP:0001935) | 1.76556892 |
| 137 | Syringomyelia (HP:0003396) | 1.75923264 |
| 138 | Spinal cord lesions (HP:0100561) | 1.75923264 |
| 139 | Aplastic anemia (HP:0001915) | 1.75829535 |
| 140 | Amyloidosis (HP:0011034) | 1.75038634 |
| 141 | Gangrene (HP:0100758) | 1.73798365 |
| 142 | Hypercholesterolemia (HP:0003124) | 1.72286066 |
| 143 | Arterial thrombosis (HP:0004420) | 1.71773936 |
| 144 | Hepatosplenomegaly (HP:0001433) | 1.70734354 |
| 145 | Pulmonary embolism (HP:0002204) | 1.70413555 |
| 146 | Acute hepatic failure (HP:0006554) | 1.70328982 |
| 147 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.70065196 |
| 148 | Osteolytic defects of the hand bones (HP:0009699) | 1.70065196 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EEF2K | 3.62742545 |
| 2 | PKN2 | 3.46573516 |
| 3 | MAP4K1 | 3.37046136 |
| 4 | PRPF4B | 3.19475054 |
| 5 | TRIB3 | 3.12953208 |
| 6 | FLT3 | 2.77962499 |
| 7 | ERN1 | 2.58050771 |
| 8 | KIT | 2.27054174 |
| 9 | MAP3K10 | 2.20624430 |
| 10 | BTK | 2.11208298 |
| 11 | TGFBR2 | 2.06383283 |
| 12 | TAOK3 | 2.02078100 |
| 13 | STK10 | 2.01541085 |
| 14 | BCKDK | 1.90139374 |
| 15 | CSF1R | 1.80043826 |
| 16 | TYK2 | 1.73325461 |
| 17 | TEC | 1.64839531 |
| 18 | TBK1 | 1.58050616 |
| 19 | GRK6 | 1.56361775 |
| 20 | SCYL2 | 1.53998578 |
| 21 | RIPK4 | 1.50754117 |
| 22 | IRAK4 | 1.50179982 |
| 23 | KSR2 | 1.48585591 |
| 24 | TTN | 1.47311330 |
| 25 | CLK1 | 1.45617561 |
| 26 | IRAK3 | 1.40919486 |
| 27 | MAP3K2 | 1.39897491 |
| 28 | MAPKAPK3 | 1.38722461 |
| 29 | JAK3 | 1.37728143 |
| 30 | SMG1 | 1.36545721 |
| 31 | PTK6 | 1.36153905 |
| 32 | PAK4 | 1.31458987 |
| 33 | FGR | 1.31093972 |
| 34 | MATK | 1.29765813 |
| 35 | RPS6KB2 | 1.28396156 |
| 36 | YES1 | 1.26713077 |
| 37 | SYK | 1.25970910 |
| 38 | * MAP2K3 | 1.25915691 |
| 39 | FES | 1.24314621 |
| 40 | * ZAP70 | 1.20401089 |
| 41 | RIPK1 | 1.18614646 |
| 42 | BMPR2 | 1.17750918 |
| 43 | JAK2 | 1.14223656 |
| 44 | CDK12 | 1.13785026 |
| 45 | ITK | 1.12716991 |
| 46 | LRRK2 | 1.11778773 |
| 47 | BLK | 1.11624070 |
| 48 | CDC7 | 1.09814635 |
| 49 | RPS6KA4 | 1.09474956 |
| 50 | TAOK1 | 1.08061840 |
| 51 | NME2 | 1.05561365 |
| 52 | TGFBR1 | 1.04022536 |
| 53 | HCK | 1.03863220 |
| 54 | CDK4 | 1.02210738 |
| 55 | PIK3CG | 1.02010002 |
| 56 | FGFR4 | 1.00928745 |
| 57 | ICK | 0.99910671 |
| 58 | CAMK1D | 0.97650203 |
| 59 | IRAK1 | 0.97508979 |
| 60 | MARK2 | 0.96971745 |
| 61 | PDPK1 | 0.95453975 |
| 62 | CDK6 | 0.95136147 |
| 63 | NEK2 | 0.94903791 |
| 64 | CSK | 0.93307381 |
| 65 | PIM1 | 0.90201670 |
| 66 | TAOK2 | 0.88496050 |
| 67 | WEE1 | 0.86621472 |
| 68 | MAP3K7 | 0.84738856 |
| 69 | * LCK | 0.83100955 |
| 70 | JAK1 | 0.81514216 |
| 71 | SIK1 | 0.80446357 |
| 72 | MAP3K12 | 0.80383850 |
| 73 | IKBKB | 0.79415367 |
| 74 | SGK3 | 0.79220896 |
| 75 | LYN | 0.78406167 |
| 76 | IKBKE | 0.77081088 |
| 77 | RAF1 | 0.76913005 |
| 78 | MAP3K11 | 0.75065807 |
| 79 | EPHB1 | 0.74048388 |
| 80 | MAPK11 | 0.73130888 |
| 81 | MAP3K14 | 0.72005206 |
| 82 | IRAK2 | 0.71679795 |
| 83 | WNK1 | 0.70882011 |
| 84 | TXK | 0.69542168 |
| 85 | MARK3 | 0.69367885 |
| 86 | MAPK12 | 0.69103248 |
| 87 | STK38 | 0.68032915 |
| 88 | TRPM7 | 0.67962962 |
| 89 | MAP3K8 | 0.67682448 |
| 90 | * RET | 0.65968149 |
| 91 | MAPK4 | 0.65814420 |
| 92 | STK24 | 0.64994316 |
| 93 | STK4 | 0.64621065 |
| 94 | SIK3 | 0.63085774 |
| 95 | PDGFRB | 0.62317946 |
| 96 | PRKD2 | 0.59772336 |
| 97 | ALK | 0.59635171 |
| 98 | CAMK1G | 0.59389214 |
| 99 | TTK | 0.57990458 |
| 100 | KSR1 | 0.57817897 |
| 101 | PASK | 0.57657134 |
| 102 | EPHA3 | 0.56979244 |
| 103 | RPS6KC1 | 0.55981817 |
| 104 | RPS6KL1 | 0.55981817 |
| 105 | DAPK1 | 0.55863977 |
| 106 | PDK1 | 0.54887056 |
| 107 | KDR | 0.54471281 |
| 108 | SIK2 | 0.53106136 |
| 109 | MAPKAPK2 | 0.52679493 |
| 110 | MAPK7 | 0.51999889 |
| 111 | ATR | 0.50492313 |
| 112 | FGFR3 | 0.49981156 |
| 113 | CDC42BPA | 0.49402200 |
| 114 | CDK9 | 0.49011392 |
| 115 | HIPK2 | 0.48400626 |
| 116 | MAP3K13 | 0.48374336 |
| 117 | MAP3K1 | 0.47976520 |
| 118 | BMX | 0.47407869 |
| 119 | MAP3K3 | 0.47181738 |
| 120 | CDK7 | 0.47095174 |
| 121 | STK3 | 0.46375507 |
| 122 | NLK | 0.46368825 |
| 123 | PTK2B | 0.46030559 |
| 124 | DMPK | 0.45015632 |
| 125 | PIK3CA | 0.44472812 |
| 126 | BRD4 | 0.44108297 |
| 127 | NEK9 | 0.41052087 |
| 128 | EGFR | 0.40926364 |
| 129 | MAPKAPK5 | 0.40212426 |
| 130 | ACVR1B | 0.40107921 |
| 131 | TNK2 | 0.38947171 |
| 132 | RPS6KA2 | 0.38903364 |
| 133 | RPS6KA6 | 0.38567434 |
| 134 | CHUK | 0.38390097 |
| 135 | CAMKK1 | 0.35360997 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.85834574 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.74138333 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.46818776 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.41984997 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.24575194 |
| 6 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.09200283 |
| 7 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.02594445 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.93309707 |
| 9 | * Leishmaniasis_Homo sapiens_hsa05140 | 1.89977550 |
| 10 | DNA replication_Homo sapiens_hsa03030 | 1.89279383 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.87597198 |
| 12 | Malaria_Homo sapiens_hsa05144 | 1.76296384 |
| 13 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.66475813 |
| 14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.65790168 |
| 15 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.59283275 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.53671672 |
| 17 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 1.49489842 |
| 18 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.49327219 |
| 19 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.49236459 |
| 20 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.47904662 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.47088030 |
| 22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.46653417 |
| 23 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.44203754 |
| 24 | Lysine degradation_Homo sapiens_hsa00310 | 1.42539543 |
| 25 | ABC transporters_Homo sapiens_hsa02010 | 1.41643589 |
| 26 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.41591199 |
| 27 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.38420919 |
| 28 | Other glycan degradation_Homo sapiens_hsa00511 | 1.36255592 |
| 29 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.32906753 |
| 30 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.31734403 |
| 31 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.29603448 |
| 32 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.29252180 |
| 33 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.25896818 |
| 34 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.25789076 |
| 35 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.24506092 |
| 36 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.24307798 |
| 37 | Peroxisome_Homo sapiens_hsa04146 | 1.23183980 |
| 38 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.20926732 |
| 39 | * Hepatitis C_Homo sapiens_hsa05160 | 1.20260355 |
| 40 | Legionellosis_Homo sapiens_hsa05134 | 1.17730500 |
| 41 | Amoebiasis_Homo sapiens_hsa05146 | 1.14585521 |
| 42 | * VEGF signaling pathway_Homo sapiens_hsa04370 | 1.13866156 |
| 43 | * TNF signaling pathway_Homo sapiens_hsa04668 | 1.11807348 |
| 44 | Carbon metabolism_Homo sapiens_hsa01200 | 1.11766002 |
| 45 | Endometrial cancer_Homo sapiens_hsa05213 | 1.11653084 |
| 46 | Insulin resistance_Homo sapiens_hsa04931 | 1.10638549 |
| 47 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.10043614 |
| 48 | Mismatch repair_Homo sapiens_hsa03430 | 1.09056389 |
| 49 | Allograft rejection_Homo sapiens_hsa05330 | 1.08248691 |
| 50 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.07115067 |
| 51 | * AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.07025070 |
| 52 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.04982803 |
| 53 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.04693468 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.04352013 |
| 55 | * Platelet activation_Homo sapiens_hsa04611 | 1.03433503 |
| 56 | Phagosome_Homo sapiens_hsa04145 | 1.03378283 |
| 57 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.02918551 |
| 58 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.02427419 |
| 59 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.02074496 |
| 60 | Galactose metabolism_Homo sapiens_hsa00052 | 1.00162398 |
| 61 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.99380438 |
| 62 | * Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.98318648 |
| 63 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.97801395 |
| 64 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.97667043 |
| 65 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.96997290 |
| 66 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.94639874 |
| 67 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.93865929 |
| 68 | * Pertussis_Homo sapiens_hsa05133 | 0.93738764 |
| 69 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.93466113 |
| 70 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.93299440 |
| 71 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.92926171 |
| 72 | * Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.90253222 |
| 73 | Lysosome_Homo sapiens_hsa04142 | 0.90115766 |
| 74 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.89961644 |
| 75 | Measles_Homo sapiens_hsa05162 | 0.89848156 |
| 76 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.89486103 |
| 77 | Viral myocarditis_Homo sapiens_hsa05416 | 0.89004376 |
| 78 | * FoxO signaling pathway_Homo sapiens_hsa04068 | 0.87694562 |
| 79 | Histidine metabolism_Homo sapiens_hsa00340 | 0.86856233 |
| 80 | * RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.86279455 |
| 81 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.85655254 |
| 82 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.84997196 |
| 83 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.84235869 |
| 84 | Glioma_Homo sapiens_hsa05214 | 0.83163509 |
| 85 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.83128605 |
| 86 | Prostate cancer_Homo sapiens_hsa05215 | 0.81463048 |
| 87 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.81018480 |
| 88 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.80603085 |
| 89 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.78804736 |
| 90 | Colorectal cancer_Homo sapiens_hsa05210 | 0.78330256 |
| 91 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.77550920 |
| 92 | Endocytosis_Homo sapiens_hsa04144 | 0.76876677 |
| 93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.76705043 |
| 94 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.76592747 |
| 95 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.75986118 |
| 96 | * Salmonella infection_Homo sapiens_hsa05132 | 0.75729259 |
| 97 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.75061977 |
| 98 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.75035484 |
| 99 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.74899908 |
| 100 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.74752908 |
| 101 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.74121908 |
| 102 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.72208375 |
| 103 | * Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.71923689 |
| 104 | * Tuberculosis_Homo sapiens_hsa05152 | 0.71307202 |
| 105 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.71276459 |
| 106 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.70805141 |
| 107 | * Toxoplasmosis_Homo sapiens_hsa05145 | 0.69189024 |
| 108 | * GnRH signaling pathway_Homo sapiens_hsa04912 | 0.68692623 |
| 109 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.67890694 |
| 110 | Hepatitis B_Homo sapiens_hsa05161 | 0.67428954 |
| 111 | * Influenza A_Homo sapiens_hsa05164 | 0.67281974 |
| 112 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.66844340 |
| 113 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.66598793 |
| 114 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.66572029 |
| 115 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.64975965 |
| 116 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.64881136 |
| 117 | * Shigellosis_Homo sapiens_hsa05131 | 0.64413080 |
| 118 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.64123407 |
| 119 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.63618711 |
| 120 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.63504063 |
| 121 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.62717882 |
| 122 | Bladder cancer_Homo sapiens_hsa05219 | 0.62560344 |
| 123 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.61546313 |
| 124 | Base excision repair_Homo sapiens_hsa03410 | 0.61151260 |
| 125 | HTLV-I infection_Homo sapiens_hsa05166 | 0.60874153 |
| 126 | Apoptosis_Homo sapiens_hsa04210 | 0.59430639 |
| 127 | Bile secretion_Homo sapiens_hsa04976 | 0.58819135 |
| 128 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.57133567 |
| 129 | Focal adhesion_Homo sapiens_hsa04510 | 0.56199481 |
| 130 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.55387811 |
| 131 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.55266780 |
| 132 | Thyroid cancer_Homo sapiens_hsa05216 | 0.54740827 |
| 133 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.52546880 |
| 134 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.52410990 |
| 135 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.51344603 |
| 136 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.50978207 |
| 137 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.50583405 |
| 138 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.50484803 |
| 139 | * Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.50206097 |
| 140 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.47872682 |
| 141 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.47094184 |
| 142 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.46754378 |
| 143 | * NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.45665003 |
| 144 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.43440208 |
| 145 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.42909209 |
| 146 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.42688727 |
| 147 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.41908965 |
| 148 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.41797293 |
| 149 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.40408885 |

